18F-FDG PET in evaluating patients treated for metastatic colorectal cancer: can we predict prognosis?
Metser
Ur
U
Tel-Aviv University, Tel-Aviv, Israel. umetser@tasmc.health.gov.il
D000465:Algorithms; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D018572:Disease-Free Survival; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000379:methods*; D011379:Prognosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18